Andrew Evens, DO MSc

Director, Lymphoma Program

Rutgers Cancer Institute of New Jersey

Dr. Evens is Associate Director for Clinical Services and Director, Lymphoma Program, Rutgers Cancer Institute; Medical Director, Oncology Service Line, RWJBarnabas Health; Associate Director for Clinical Services; Medical Director of the Oncology Service Line for RWJ Barnabas Health; and Director of the Lymphoma Program. He served as the director of the Cancer Center at Tufts Medical Center in Boston, chief of their division of hematology/oncology, and Professor of Medicine at Tufts University School of Medicine

Dr Evens is an expert in Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation. He manages a translational laboratory studying the biology of lymphoma and to discover new and novel treatments for patients.

Dr. Evens a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and a member of several additional clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group. He is also Vice-Chair of the Lymphoma Committee for the ECOG-ACRIN cancer research group and an elected member of the North American Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and a member of the Board of Trustees for the Leukemia & Lymphoma Society (LLS) New Jersey Chapter.

Dr. Evens completed a prior fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where he remained as a faculty member altogether for 10 years.